Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

BEIJING -- A group of Chinese researchers has developed a wearable repetitive transcranial magnetic stimulation (rTMS) device ...

Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.

Newronika has received an investigational device exemption (IDE) for its adaptive deep brain stimulation (DBS ... approval for AlphaDBS, a closed-loop brain neuromodulation implant in the country.

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach ...

is the world’s first and only closed-loop brain-responsive neurostimulation system for the disease. The RNS System treats seizures by continuously monitoring brain waves, detecting unusual ...

The world's best clinics achieve success in Parkinson’s treatment by individualizing deep brain stimulation (DBS) through ...

An update to the traditional deep brain stimulation device enables adaptive pulses of electricity that help to lessen the symptoms of Parkinson’s disease and inform future research.

New closed-loop system self-adjusts DBS therapy to ... neurological conditions like Parkinson's, however, deep brain stimulation (DBS) has been transforming the lives of people with Parkinson's ...

Newronika's AlphaDBS monitors the patient's brain activity and automatically adjusts stimulation levels in response to ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...